<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" open-status="O" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d1 20130915//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 39.96?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Med Genet</journal-id><journal-id journal-id-type="iso-abbrev">J. Med. Genet</journal-id><journal-id journal-id-type="hwp">jmedgenet</journal-id><journal-id journal-id-type="publisher-id">jmg</journal-id><journal-title-group><journal-title>Journal of Medical Genetics</journal-title></journal-title-group><issn pub-type="ppub">0022-2593</issn><issn pub-type="epub">1468-6244</issn><publisher><publisher-name>BMJ Publishing Group</publisher-name><publisher-loc>BMA House, Tavistock Square, London, WC1H 9JR</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5366069</article-id><article-id pub-id-type="pmid">27884935</article-id><article-id pub-id-type="publisher-id">jmedgenet-2016-104215</article-id><article-id pub-id-type="doi">10.1136/jmedgenet-2016-104215</article-id><article-categories><subj-group subj-group-type="hwp-journal-coll"><subject>1506</subject></subj-group><subj-group subj-group-type="heading"><subject>Developmental Defects</subject></subj-group><series-title>Original article</series-title></article-categories><title-group><article-title><SecTag type="TITLE"><text><SENT sid="53916" pm="."><plain>Diagnostic value of exome and whole genome sequencing in craniosynostosis </plain></SENT>
</text></SecTag></article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-2278-155X</contrib-id><name><surname>Miller</surname><given-names>Kerry A</given-names></name><xref ref-type="aff" rid="af1">1</xref></contrib><contrib contrib-type="author"><name><surname>Twigg</surname><given-names>Stephen R F</given-names></name><xref ref-type="aff" rid="af1">1</xref></contrib><contrib contrib-type="author"><name><surname>McGowan</surname><given-names>Simon J</given-names></name><xref ref-type="aff" rid="af2">2</xref></contrib><contrib contrib-type="author"><name><surname>Phipps</surname><given-names>Julie M</given-names></name><xref ref-type="aff" rid="af1">1</xref><xref ref-type="aff" rid="af3">3</xref></contrib><contrib contrib-type="author"><name><surname>Fenwick</surname><given-names>Aimée L</given-names></name><xref ref-type="aff" rid="af1">1</xref></contrib><contrib contrib-type="author"><name><surname>Johnson</surname><given-names>David</given-names></name><xref ref-type="aff" rid="af4">4</xref></contrib><contrib contrib-type="author"><name><surname>Wall</surname><given-names>Steven A</given-names></name><xref ref-type="aff" rid="af4">4</xref></contrib><contrib contrib-type="author"><name><surname>Noons</surname><given-names>Peter</given-names></name><xref ref-type="aff" rid="af5">5</xref></contrib><contrib contrib-type="author"><name><surname>Rees</surname><given-names>Katie E M</given-names></name><xref ref-type="aff" rid="af6">6</xref></contrib><contrib contrib-type="author"><name><surname>Tidey</surname><given-names>Elizabeth A</given-names></name><xref ref-type="aff" rid="af6">6</xref></contrib><contrib contrib-type="author"><name><surname>Craft</surname><given-names>Judith</given-names></name><xref ref-type="aff" rid="af7">7</xref></contrib><contrib contrib-type="author"><name><surname>Taylor</surname><given-names>John</given-names></name><xref ref-type="aff" rid="af7">7</xref></contrib><contrib contrib-type="author"><name><surname>Taylor</surname><given-names>Jenny C</given-names></name><xref ref-type="aff" rid="af8">8</xref><xref ref-type="aff" rid="af9">9</xref></contrib><contrib contrib-type="author"><name><surname>Goos</surname><given-names>Jacqueline A C</given-names></name><xref ref-type="aff" rid="af10">10</xref></contrib><contrib contrib-type="author"><name><surname>Swagemakers</surname><given-names>Sigrid M A</given-names></name><xref ref-type="aff" rid="af11">11</xref></contrib><contrib contrib-type="author"><name><surname>Mathijssen</surname><given-names>Irene M J</given-names></name><xref ref-type="aff" rid="af10">10</xref></contrib><contrib contrib-type="author"><name><surname>van der Spek</surname><given-names>Peter J</given-names></name><xref ref-type="aff" rid="af11">11</xref></contrib><contrib contrib-type="author"><name><surname>Lord</surname><given-names>Helen</given-names></name><xref ref-type="aff" rid="af7">7</xref></contrib><contrib contrib-type="author"><name><surname>Lester</surname><given-names>Tracy</given-names></name><xref ref-type="aff" rid="af7">7</xref></contrib><contrib contrib-type="author"><name><surname>Abid</surname><given-names>Noina</given-names></name><xref ref-type="aff" rid="af12">12</xref></contrib><contrib contrib-type="author"><name><surname>Cilliers</surname><given-names>Deirdre</given-names></name><xref ref-type="aff" rid="af3">3</xref><xref ref-type="aff" rid="af4">4</xref></contrib><contrib contrib-type="author"><name><surname>Hurst</surname><given-names>Jane A</given-names></name><xref ref-type="aff" rid="af6">6</xref></contrib><contrib contrib-type="author"><name><surname>Morton</surname><given-names>Jenny E V</given-names></name><xref ref-type="aff" rid="af13">13</xref></contrib><contrib contrib-type="author"><name><surname>Sweeney</surname><given-names>Elizabeth</given-names></name><xref ref-type="aff" rid="af14">14</xref></contrib><contrib contrib-type="author"><name><surname>Weber</surname><given-names>Astrid</given-names></name><xref ref-type="aff" rid="af14">14</xref></contrib><contrib contrib-type="author"><name><surname>Wilson</surname><given-names>Louise C</given-names></name><xref ref-type="aff" rid="af6">6</xref></contrib><contrib contrib-type="author"><name><surname>Wilkie</surname><given-names>Andrew O M</given-names></name><xref ref-type="aff" rid="af1">1</xref><xref ref-type="aff" rid="af3">3</xref><xref ref-type="aff" rid="af4">4</xref></contrib></contrib-group><aff id="af1">
<label>1</label><addr-line>Clinical Genetics Group</addr-line>, <institution>Weatherall Institute of Molecular Medicine, University of Oxford</institution>, <addr-line>Oxford</addr-line>, <country>UK</country></aff><aff id="af2">
<label>2</label><addr-line>Computational Biology Research Group</addr-line>, <institution>Weatherall Institute of Molecular Medicine, University of Oxford</institution>, <addr-line>Oxford</addr-line>, <country>UK</country></aff><aff id="af3">
<label>3</label><addr-line>Department of Clinical Genetics</addr-line>, <institution>Oxford University Hospitals NHS Foundation Trust</institution>, <addr-line>Oxford</addr-line>, <country>UK</country></aff><aff id="af4">
<label>4</label><addr-line>Craniofacial Unit</addr-line>, <institution>Oxford University Hospitals NHS Foundation Trust</institution>, <addr-line>Oxford</addr-line>, <country>UK</country></aff><aff id="af5">
<label>5</label><addr-line>Department of Craniofacial Surgery</addr-line>, <institution>Birmingham Children's Hospital NHS Foundation Trust</institution>, <addr-line>Birmingham</addr-line>, <country>UK</country></aff><aff id="af6">
<label>6</label><addr-line>North East Thames Regional Genetics Service</addr-line>, <institution>Great Ormond Street Hospital for Children NHS Foundation Trust</institution>, <addr-line>London</addr-line>, <country>UK</country></aff><aff id="af7">
<label>7</label><addr-line>Oxford Medical Genetics Laboratories</addr-line>, <institution>Oxford University Hospitals NHS Foundation Trust</institution>, <addr-line>Oxford</addr-line>, <country>UK</country></aff><aff id="af8">
<label>8</label><institution>Oxford Biomedical Research Centre, National Institute for Health Research</institution>, <addr-line>Oxford</addr-line>, <country>UK</country></aff><aff id="af9">
<label>9</label><institution>Wellcome Trust Centre for Human Genetics</institution>, <institution>University of Oxford</institution>, <addr-line>Oxford</addr-line>, <country>UK</country></aff><aff id="af10">
<label>10</label><addr-line>Department of Plastic and Reconstructive Surgery and Hand Surgery</addr-line>, <institution>Erasmus Medical Centre, University Medical Centre Rotterdam</institution>, <addr-line>Rotterdam</addr-line>, <country>The Netherlands</country></aff><aff id="af11">
<label>11</label><addr-line>Department of Bioinformatics</addr-line>, <institution>Erasmus Medical Centre, University Medical Centre Rotterdam</institution>, <addr-line>Rotterdam</addr-line>, <country>The Netherlands</country></aff><aff id="af12">
<label>12</label><addr-line>Department of Paediatric Endocrinology</addr-line>, <institution>The Royal Belfast Hospital for Sick Children</institution>, <addr-line>Belfast</addr-line>, <country>UK</country></aff><aff id="af13">
<label>13</label><addr-line>Clinical Genetics Unit</addr-line>, <institution>Birmingham Women's Hospital NHS Foundation Trust</institution>, <addr-line>Birmingham</addr-line>, <country>UK</country></aff><aff id="af14">
<label>14</label><addr-line>Department of Clinical Genetics</addr-line>, <institution>Liverpool Women's NHS Foundation Trust</institution>, <addr-line>Liverpool</addr-line>, <country>UK</country></aff><author-notes><corresp><label>Correspondence to</label> Professor Andrew O M Wilkie, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DS, UK; <email>andrew.wilkie@imm.ox.ac.uk</email></corresp></author-notes><pub-date pub-type="ppub"><month>4</month><year>2017</year></pub-date><pub-date pub-type="epub"><day>24</day><month>11</month><year>2016</year></pub-date><volume>54</volume><issue>4</issue><fpage>260</fpage><lpage>268</lpage><history><date date-type="received"><day>24</day><month>8</month><year>2016</year></date><date date-type="rev-recd"><day>26</day><month>9</month><year>2016</year></date><date date-type="accepted"><day>19</day><month>10</month><year>2016</year></date></history><permissions><copyright-statement>Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/</copyright-statement><copyright-year>2016</copyright-year><license license-type="open-access"><license-p>This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link></license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="jmedgenet-2016-104215.pdf"/><abstract><sec><title><text><SENT sid="53917" pm="."><plain>Background </plain></SENT>
</text></title><p><SecTag type="ABS"><text><SENT sid="53918" pm="."><plain>Craniosynostosis, the premature fusion of one or more cranial sutures, occurs in ∼1 in 2250 births, either in isolation or as part of a syndrome. </plain></SENT>
<SENT sid="53919" pm="."><plain>Mutations in at least 57 genes have been associated with craniosynostosis, but only a minority of these are included in routine laboratory genetic testing. </plain></SENT>
</text></SecTag></p></sec><sec><title><text><SENT sid="53920" pm="."><plain>Methods </plain></SENT>
</text></title><p><SecTag type="ABS"><text><SENT sid="53921" pm="."><plain>We used exome or whole genome sequencing to seek a genetic cause in a cohort of 40 subjects with craniosynostosis, selected by clinical or molecular geneticists as being high-priority cases, and in whom prior clinically driven genetic testing had been negative. </plain></SENT>
</text></SecTag></p></sec><sec><title><text><SENT sid="53922" pm="."><plain>Results </plain></SENT>
</text></title><p><SecTag type="ABS"><text><SENT sid="53923" pm="."><plain>We identified likely associated mutations in 15 patients (37.5%), involving 14 different genes. </plain></SENT>
<SENT sid="53924" pm="."><plain>All genes were mutated in single families, except for IL11RA (two families). </plain></SENT>
<SENT sid="53925" pm="."><plain>We classified the other positive diagnoses as follows: commonly mutated craniosynostosis genes with atypical presentation (EFNB1, TWIST1); other core craniosynostosis genes (CDC45, MSX2, ZIC1); genes for which mutations are only rarely associated with craniosynostosis (FBN1, HUWE1, KRAS, STAT3); and known disease genes for which a causal relationship with craniosynostosis is currently unknown (AHDC1, NTRK2). </plain></SENT>
<SENT sid="53926" pm="."><plain>In two further families, likely novel disease genes are currently undergoing functional validation. </plain></SENT>
<SENT sid="53927" pm="."><plain>In 5 of the 15 positive cases, the (previously unanticipated) molecular diagnosis had immediate, actionable consequences for either genetic or medical management (mutations in EFNB1, FBN1, KRAS, NTRK2, STAT3). </plain></SENT>
</text></SecTag></p></sec><sec><title><text><SENT sid="53928" pm="."><plain>Conclusions </plain></SENT>
</text></title><p><SecTag type="ABS"><text><SENT sid="53929" pm="."><plain>This substantial genetic heterogeneity, and the multiple actionable mutations identified, emphasises the benefits of exome/whole genome sequencing to identify causal mutations in craniosynostosis cases for which routine clinical testing has yielded negative results. </plain></SENT>
</text></SecTag></p></sec></abstract><SecTag type="KEYWORD"><kwd-group><kwd>Craniosynostosis</kwd><kwd>Exome/whole genome sequencing</kwd><kwd>Actionable mutation</kwd></kwd-group></SecTag><custom-meta-group><custom-meta><meta-name>special-feature</meta-name><meta-value>unlocked</meta-value></custom-meta></custom-meta-group></article-meta></front><body><SecTag type="INTRO"><sec sec-type="intro" id="s1"><title><text><SENT sid="53930" pm="."><plain>Introduction </plain></SENT>
</text></title><p><text><SENT sid="53931" pm="."><plain>Accurate molecular classification is critical for the clinical management, counselling and prognosis of individuals with suspected monogenic diseases, particularly where early diagnosis and intervention would substantially influence decision-making by the clinician or family. </plain></SENT>
<SENT sid="53932" pm="."><plain>Traditional phenotypically guided genetic testing may fail to identify rarer causes of disease as many conditions have a highly variable clinical presentation. </plain></SENT>
<SENT sid="53933" pm="."><plain>The use of next-generation sequencing (NGS) technologies to interrogate the exome sequence (ES) or whole genome sequence (WGS) may circumvent some of these difficulties since these approaches are agnostic to the underlying genetic cause.1–3 </plain></SENT>
</text></p><p><text><SENT sid="53934" pm="."><plain>Craniosynostosis, a condition that affects ∼1 in 2250 births,4 5 is defined as the premature fusion of one or more of the normally patent cranial sutures, a consequence of disruption in the coordinated patterning, proliferation and differentiation of these tissues.6 It has a highly heterogeneous and complex aetiology with contributions from monogenic, chromosomal, polygenic and environmental factors all playing a role.7 8 Craniosynostosis most commonly occurs in isolation, but a minority of cases are associated with additional clinical features as part of a syndrome, probably reflecting the co-option of pleiotropic signalling pathways to pattern and maintain the suture; association with &gt;100 human syndromes has been reported.9 An underlying genetic cause can be identified in ∼24% of cases, with mutations in just six genes (in decreasing order of frequency: FGFR2, FGFR3, TWIST1, TCF12, ERF and EFNB1) together accounting for over three-quarters of monogenic diagnoses.10–19 At least 52 other genes have been identified as recurrently mutated in craniosynostosis,8 20 but these rarer targets do not tend to be included in molecular testing panels unless indicated by specific clinical features. </plain></SENT>
<SENT sid="53935" pm="."><plain>Craniosynostosis may also present as a low-frequency association with intellectual disability syndromes, possibly related to disturbed maintenance of suture patency.8 </plain></SENT>
</text></p><p><text><SENT sid="53936" pm="."><plain>To evaluate the utility of ES and WGS in this context, we used these technologies to search for a molecular diagnosis in 40 patients with craniosynostosis who had previously been evaluated using existing routine molecular testing, without a diagnosis being made. </plain></SENT>
<SENT sid="53937" pm="."><plain>Cases were identified as being of high priority for further investigation either by craniofacial clinical geneticists or by laboratory scientists specialising in craniofacial molecular diagnostics. </plain></SENT>
<SENT sid="53938" pm="."><plain>From this cohort, we identified an underlying molecular lesion in 15 (37.5%) families. </plain></SENT>
<SENT sid="53939" pm="."><plain>We document several cases where the mutation identified either did not obviously fit with the original clinical diagnosis or where identification of the causal mutation would have proved difficult using traditional methods of molecular testing. </plain></SENT>
<SENT sid="53940" pm="."><plain>We highlight five families for which diagnosis has immediately impacted on clinical management or counselling. </plain></SENT>
<SENT sid="53941" pm="."><plain>This work illustrates the molecular diversity of causes of craniosynostosis and the added value that can be gained by a comprehensive diagnostic approach in difficult cases. </plain></SENT>
</text></p></sec></SecTag><SecTag type="METHODS"><sec id="s2"><title><text><SENT sid="53942" pm="."><plain>Subjects and methods </plain></SENT>
</text></title><sec id="s2a"><title><text><SENT sid="53943" pm="."><plain>Ethics statement and prior clinical investigation </plain></SENT>
</text></title><p><text><SENT sid="53944" pm="."><plain>Written, informed consent for genetic research and publication of clinical photographs was obtained by the referring clinicians and their research teams. </plain></SENT>
<SENT sid="53945" pm="."><plain>DNA was extracted from whole blood. </plain></SENT>
<SENT sid="53946" pm="."><plain>Genetic testing by a clinically accredited laboratory was guided by the judgement of the referring clinician and diagnostic laboratory but usually included dideoxy sequencing of TWIST1, TCF12 and ERF (entire gene), FGFR2 and FGFR3 (regions enriched for craniosynostosis-associated mutations) and multiplex-ligation-dependent probe amplification of TWIST1 to exclude heterozygous deletions.7 17 18 Since chromosomal abnormalities account for 13–15% of genetic diagnoses in craniosynostosis,10 17 a karyotype or array comparative genomic hybridisation was undertaken in the majority of cases. </plain></SENT>
</text></p></sec><sec id="s2b"><title><text><SENT sid="53947" pm="."><plain>Cohort description </plain></SENT>
</text></title><p><text><SENT sid="53948" pm="."><plain>Subjects with craniosynostosis, who had previously been investigated by molecular genetic testing with normal findings, were identified either by four clinical geneticists with specialist expertise in craniosynostosis (n=36) or by clinical laboratory scientists working in a specialist genetic diagnostic service (n=20) for further investigation. </plain></SENT>
<SENT sid="53949" pm="."><plain>Clinical geneticists were asked to prioritise cases thought most likely to have a genetic diagnosis (based on presence of syndromic features, multiple sutures affected, consanguinity or positive family history, and lack of any obvious environmental predisposition), particularly where there were active issues with genetic counselling. </plain></SENT>
<SENT sid="53950" pm="."><plain>Twelve of the cases initially identified by clinical geneticists were excluded either because further targeted genetic testing identified a monogenic cause (one case each with mutations in ERF,18 FGFR211 and FLNA,21 and two with IL11RA mutations),22 where enrolment into the Deciphering Developmental Disorders study 3 was considered more appropriate (n=5) or where samples were not available for analysis (n=2). </plain></SENT>
<SENT sid="53951" pm="."><plain>The remaining cases (n=24), together with parental samples (where available), were enrolled into the craniofacial research study following informed consent. </plain></SENT>
<SENT sid="53952" pm="."><plain>Sequencing comprised 12 singletons, 1 parent–child duo, 10 parent–child trios and 1 trio comprising three affected individuals. </plain></SENT>
<SENT sid="53953" pm="."><plain>Similar criteria were used by clinical laboratory scientists to prioritise 20 cases for ES; however, clinical information tended to be more limited and availability of sufficient stored DNA sample was often a decisive factor for case inclusion. </plain></SENT>
<SENT sid="53954" pm="."><plain>For the laboratory samples, consent for research investigation was sought secondarily to enable the entire exome to be interrogated; two cases were excluded because consent was not obtained. </plain></SENT>
<SENT sid="53955" pm="."><plain>In 16 of the remaining 18 laboratory diagnostic cases, ES was performed on the proband only; in one instance, the exome of an affected sibling was already available, and in another the family trio subsequently had WGS. </plain></SENT>
<SENT sid="53956" pm="."><plain>Two duplicate families (29 and 34) identified by both clinicians and laboratory scientists are listed under the latter category in table 1, which summarises the patterns of cranial suture involvement and syndromic features of the final total of 40 patients/families analysed, with further details in online supplementary table S1. </plain></SENT>
<SENT sid="53957" pm="."><plain>In general, cases referred by clinical geneticists exhibited higher proportions of multisuture involvement and syndromic features (table 1). </plain></SENT>
<SENT sid="53958" pm="."><plain>The significance of differences between two groups was calculated using Fisher's exact test. </plain></SENT>
</text></p><supplementary-material content-type="local-data" id="SM1"><object-id pub-id-type="doi">10.1136/jmedgenet-2016-104215.supp1</object-id><label>supplementary table 1</label><p><text><SENT sid="53959" pm="."><plain> </plain></SENT>
</text></p></supplementary-material><SecTag type="TABLE"><table-wrap id="JMEDGENET2016104215TB1" orientation="portrait" position="float"><label>Table 1</label><caption><p><text><SENT sid="53960" pm="."><plain>Cranial suture involvement in patients recruited for exome sequence/whole genome sequence </plain></SENT>
</text></p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="char" char="." span="1"/><col align="left" span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/></colgroup><thead valign="bottom"><tr><th align="left" rowspan="1" colspan="1"/><th align="left" colspan="2" rowspan="1"><text><SENT sid="53961" pm="."><plain>Non-syndromic </plain></SENT>
</text></th><th align="left" colspan="2" rowspan="1"><text><SENT sid="53962" pm="."><plain>Syndromic </plain></SENT>
</text></th><th align="left" colspan="2" rowspan="1"><text><SENT sid="53963" pm="."><plain>Combined </plain></SENT>
</text></th></tr><tr><th rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1"><text><SENT sid="53964" pm="."><plain>Total </plain></SENT>
</text></th><th align="left" rowspan="1" colspan="1"><text><SENT sid="53965" pm="."><plain>Mutation positive </plain></SENT>
</text></th><th align="left" rowspan="1" colspan="1"><text><SENT sid="53966" pm="."><plain>Total </plain></SENT>
</text></th><th align="left" rowspan="1" colspan="1"><text><SENT sid="53967" pm="."><plain>Mutation positive </plain></SENT>
</text></th><th align="left" rowspan="1" colspan="1"><text><SENT sid="53968" pm="."><plain>Total </plain></SENT>
</text></th><th align="left" rowspan="1" colspan="1"><text><SENT sid="53969" pm="."><plain>Mutation positive </plain></SENT>
</text></th></tr></thead><tbody><tr><td colspan="7" rowspan="1"><text><SENT sid="53970" pm="."><plain>Clinical genetic cases </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="53971" pm="."><plain> Metopic </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="53972" pm="."><plain>0 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="53973" pm="."><plain>0 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="53974" pm="."><plain>2 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="53975" pm="."><plain>2 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="53976" pm="."><plain>2 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="53977" pm="."><plain>2 </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="53978" pm="."><plain> Sagittal </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="53979" pm="."><plain>0 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="53980" pm="."><plain>0 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="53981" pm="."><plain>0 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="53982" pm="."><plain>0 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="53983" pm="."><plain>0 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="53984" pm="."><plain>0 </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="53985" pm="."><plain> Unicoronal </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="53986" pm="."><plain>0 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="53987" pm="."><plain>0 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="53988" pm="."><plain>1 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="53989" pm="."><plain>0 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="53990" pm="."><plain>1 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="53991" pm="."><plain>0 </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="53992" pm="."><plain> Bicoronal </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="53993" pm="."><plain>2 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="53994" pm="."><plain>0 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="53995" pm="."><plain>2 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="53996" pm="."><plain>2 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="53997" pm="."><plain>4 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="53998" pm="."><plain>2 </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="53999" pm="."><plain> Multisuture </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54000" pm="."><plain>3 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54001" pm="."><plain>1 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54002" pm="."><plain>12 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54003" pm="."><plain>5* </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54004" pm="."><plain>15 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54005" pm="."><plain>6 </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="54006" pm="."><plain> Total </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54007" pm="."><plain>5 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54008" pm="."><plain>1 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54009" pm="."><plain>17 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54010" pm="."><plain>9 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54011" pm="."><plain>22 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54012" pm="."><plain>10 </plain></SENT>
</text></td></tr><tr><td colspan="7" rowspan="1"><text><SENT sid="54013" pm="."><plain>Molecular genetic cases </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="54014" pm="."><plain> Metopic </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54015" pm="."><plain>0 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54016" pm="."><plain>0 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54017" pm="."><plain>0 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54018" pm="."><plain>0 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54019" pm="."><plain>0 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54020" pm="."><plain>0 </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="54021" pm="."><plain> Sagittal </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54022" pm="."><plain>0 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54023" pm="."><plain>0 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54024" pm="."><plain>2 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54025" pm="."><plain>0 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54026" pm="."><plain>2 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54027" pm="."><plain>0 </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="54028" pm="."><plain> Unicoronal </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54029" pm="."><plain>5 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54030" pm="."><plain>1 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54031" pm="."><plain>1 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54032" pm="."><plain>1 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54033" pm="."><plain>6 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54034" pm="."><plain>2 </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="54035" pm="."><plain> Bicoronal </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54036" pm="."><plain>2 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54037" pm="."><plain>0 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54038" pm="."><plain>2 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54039" pm="."><plain>1* </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54040" pm="."><plain>4 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54041" pm="."><plain>1 </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="54042" pm="."><plain> Multisuture </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54043" pm="."><plain>1 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54044" pm="."><plain>0 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54045" pm="."><plain>5 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54046" pm="."><plain>2 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54047" pm="."><plain>6 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54048" pm="."><plain>2 </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="54049" pm="."><plain> Total </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54050" pm="."><plain>8 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54051" pm="."><plain>1 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54052" pm="."><plain>10 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54053" pm="."><plain>4 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54054" pm="."><plain>18 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54055" pm="."><plain>5 </plain></SENT>
</text></td></tr></tbody></table><table-wrap-foot><fn><p><text><SENT sid="54056" pm="."><plain>*Includes likely novel disease gene, still undergoing validation. </plain></SENT>
</text></p></fn></table-wrap-foot></table-wrap></SecTag></sec><sec id="s2c"><title><text><SENT sid="54057" pm="."><plain>Exome and whole genome sequencing </plain></SENT>
</text></title><p><text><SENT sid="54058" pm="."><plain>Exome capture of DNA from patients was carried out using the TruSeq v2 (Illumina), SureSelect Human All Exon Kit v4/v5 (Agilent) or SeqCap EZ Human Exome Library v2.0 (NimbleGen) following the manufacturer's instructions. </plain></SENT>
<SENT sid="54059" pm="."><plain>We generated a library for each sample using DNA extracted from whole blood; usually we employed 3 μg DNA, except for SureSelect v5 processed samples from families 8, 16 and 17 only, for which we used 200 ng DNA. </plain></SENT>
<SENT sid="54060" pm="."><plain>ES was performed on an Illumina HiSeq 2000 or 4000, with 75  or 100 bp paired-end reads. </plain></SENT>
<SENT sid="54061" pm="."><plain>WGS was performed on 5 μg DNA extracted from blood by Complete Genomics (a BGI Company) and analysed as previously described.23 </plain></SENT>
</text></p></sec><sec id="s2d"><title><text><SENT sid="54062" pm="."><plain>Bioinformatic analysis </plain></SENT>
</text></title><p><text><SENT sid="54063" pm="."><plain>ES reads were mapped to the GRCh38 reference genome with Bowtie 224 and removal of artefacts (unmapped sequences, duplicate PCR products and likely pseudogene sequences) using custom Perl scripts.18 Variants were called using SAMtools v1.125 and Platypus v0.5.2.26 Sequence reads from WGS were mapped to the GRCh37 reference genome and analysed as previously described.23 The pathogenicity of each variant was given a custom deleterious score based on a six-point scale,27 calculated using output from ANNOVAR.28 Variants predicted to affect splicing were assigned a deleterious score based on MaxEntScan score differences,29 and the relationship of variants present in known disease-causing genes analysed for pathogenicity using ClinVar.30 Variants with minor allele frequency (MAF) &gt;1% in dbSNP or ExAC were removed, and remaining variants examined manually by visualisation in GBrowse (hg37/hg38).31 </plain></SENT>
</text></p><p><text><SENT sid="54064" pm="."><plain>In families comprising parent–child trios with a sporadic affected individual, we evaluated variants based on all likely modes of inheritance; de novo mutation, recessive (homozygous and compound heterozygous) and X-linked hemizygous variants (in males). </plain></SENT>
<SENT sid="54065" pm="."><plain>For cases in which the parents were known to be related, the proband was usually sequenced as a singleton and the data interrogated for homozygous changes. </plain></SENT>
<SENT sid="54066" pm="."><plain>For all samples, data were analysed for variants in 57 genes recurrently mutated in craniosynostosis8 and 1313 genes curated as being mutated in developmental disorders.3 </plain></SENT>
</text></p></sec><sec id="s2e"><title><text><SENT sid="54067" pm="."><plain>Variant validation </plain></SENT>
</text></title><p><text><SENT sid="54068" pm="."><plain>Confirmation of variants was carried out by dideoxy sequencing or restriction digest of genomic PCR amplification products. </plain></SENT>
<SENT sid="54069" pm="."><plain>Primer sequences and conditions are detailed in online supplementary table S2. </plain></SENT>
<SENT sid="54070" pm="."><plain>Amplification products were sequenced using the BigDye Terminator v3.1 cycle sequencer system (Applied Biosystems) and visualised using BioEdit Sequence Alignment Editor (Ibis Biosciences) and Mutation Surveyor Software (SoftGenetics). </plain></SENT>
</text></p><supplementary-material content-type="local-data" id="SM2"><object-id pub-id-type="doi">10.1136/jmedgenet-2016-104215.supp2</object-id><label>supplementary table 2</label><p><text><SENT sid="54071" pm="."><plain> </plain></SENT>
</text></p></supplementary-material><p><text><SENT sid="54072" pm="."><plain>Where a previously undescribed de novo variant was identified in a singleton sample (ie, HUWE1), correct sample relationships of the trio were checked by demonstrating consistent inheritance of nine microsatellite loci (D1S2826, D3S1311, D5S2027, D6S1610, D9S158, D10S548, D13S1265, D14S280 and D18S474), labelled with 6-FAM fluorescent tags. </plain></SENT>
</text></p></sec></sec></SecTag><SecTag type="RESULTS"><sec sec-type="results" id="s3"><title><text><SENT sid="54073" pm="."><plain>Results </plain></SENT>
</text></title><sec id="s3a"><title><text><SENT sid="54074" pm="."><plain>Overview of molecular findings </plain></SENT>
</text></title><p><text><SENT sid="54075" pm="."><plain>We used either ES (n=37) or WGS (n=3) to seek a causative mutation in the two patient cohorts. </plain></SENT>
<SENT sid="54076" pm="."><plain>In the cases from clinical geneticists (n=22), interpretation was often assisted by sequencing samples from unaffected parents or affected first-degree relatives; 23 additional samples were sequenced in this group (see online supplementary table S1). </plain></SENT>
<SENT sid="54077" pm="."><plain>For most cases from the diagnostic laboratory, samples from relatives were either unavailable or not consented for analysis of ES/WGS (as described above) and, with two exceptions (total of three additional samples sequenced), these cases were analysed as singletons. </plain></SENT>
</text></p><p><text><SENT sid="54078" pm="."><plain>Mutations considered to be clinically significant (for the diagnosis of craniosynostosis and/or another genetic disorder) were identified in 15 of the 40 patients (37.5%), including two cases associated with putative novel disease genes that are still undergoing validation (table 2). </plain></SENT>
<SENT sid="54079" pm="."><plain>Significantly more positive diagnoses were found in syndromic (13/27) than non-syndromic (2/13) patients (one-tailed p=0.046). </plain></SENT>
<SENT sid="54080" pm="."><plain>The number of mutations identified in patients recruited via clinical geneticists (including the two duplicate ascertainments) was higher (11/24; 46%) compared with those recruited via the diagnostic laboratory (5/18; 28%), likely a consequence of more rigorous clinical selection and inclusion of sequencing data from a greater number of additional family members in these cases; however, the difference was not significant (one-tailed p=0.19). </plain></SENT>
<SENT sid="54081" pm="."><plain>A positive diagnosis was obtained in a higher proportion of families in which multiple individuals were sequenced (6/14; 43%) than when singletons were sequenced (9/26; 35%), but this difference was also not significant. </plain></SENT>
<SENT sid="54082" pm="."><plain>When the case solution rate was analysed in terms of total samples sequenced, sequencing of multiple individuals in a family appeared less cost-effective (six solved using a total of 40 ES/WGS; an efficiency of 0.43 per exome/genome sequenced compared with singleton sequencing). </plain></SENT>
</text></p><SecTag type="TABLE"><table-wrap id="JMEDGENET2016104215TB2" orientation="portrait" position="float"><label>Table 2</label><caption><p><text><SENT sid="54083" pm="."><plain>Summary details of patients with a positive genetic diagnosis </plain></SENT>
</text></p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/></colgroup><thead valign="bottom"><tr><th align="left" rowspan="1" colspan="1"><text><SENT sid="54084" pm="."><plain>Family </plain></SENT>
</text></th><th align="left" rowspan="1" colspan="1"><text><SENT sid="54085" pm="."><plain>Sex </plain></SENT>
</text></th><th align="left" rowspan="1" colspan="1"><text><SENT sid="54086" pm="."><plain>GENE </plain></SENT>
</text></th><th align="left" colspan="2" rowspan="1"><text><SENT sid="54087" pm="."><plain>Mutation </plain></SENT>
</text></th><th align="left" rowspan="1" colspan="1"><text><SENT sid="54088" pm="."><plain>Inheritance </plain></SENT>
</text></th><th align="left" rowspan="1" colspan="1"><text><SENT sid="54089" pm="."><plain>Ref </plain></SENT>
</text></th><th align="left" rowspan="1" colspan="1"><text><SENT sid="54090" pm="."><plain>CRS </plain></SENT>
</text></th><th align="left" rowspan="1" colspan="1"><text><SENT sid="54091" pm="."><plain>Clinical features† </plain></SENT>
</text></th></tr></thead><tbody><tr><td rowspan="1" colspan="1"><text><SENT sid="54092" pm="."><plain>3 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54093" pm="."><plain>F </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54094" pm="."><plain>CDC45 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54095" pm="."><plain>c.[226A&gt;C];[469C&gt;T] </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54096" pm="."><plain>p.[N76H];[R157C] </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54097" pm="."><plain>Compound heterozygous </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54098" pm="."><plain>32 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54099" pm="."><plain>BC </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54100" pm="."><plain>Short stature, thin eyebrows, anteriorly placed anus </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="54101" pm="."><plain>4 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54102" pm="."><plain>M </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54103" pm="."><plain>IL11RA </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54104" pm="."><plain>c.[886C&gt;T];[886C&gt;T] </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54105" pm="."><plain>p.[R296W];[R296W] </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54106" pm="."><plain>Homozygous </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54107" pm="."><plain>22 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54108" pm="."><plain>P </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54109" pm="."><plain>Exorbitism, intellectual disability, atopy. ?Crouzon syndrome </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="54110" pm="."><plain>7 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54111" pm="."><plain>F </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54112" pm="."><plain>Novel‡ </plain></SENT>
</text></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"><text><SENT sid="54113" pm="."><plain>Homozygous </plain></SENT>
</text></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"><text><SENT sid="54114" pm="."><plain>P </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54115" pm="."><plain>Mid-face hypoplasia, corneal ulceration, scoliosis, severe respiratory tract infections/bronchiectasis, mild–moderate developmental delay </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="54116" pm="."><plain>9 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54117" pm="."><plain>M </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54118" pm="."><plain>IL11RA </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54119" pm="."><plain>c.[98dupC];[98dupC] </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54120" pm="."><plain>p.[G34fs*39];[G34fs*39] </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54121" pm="."><plain>Homozygous </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54122" pm="."><plain>– </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54123" pm="."><plain>S, BC </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54124" pm="."><plain>Crouzonoid facies, mild developmental delay, dental anomalies, patent ductus arteriosus, atrial septal defect, umbilical hernia </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="54125" pm="."><plain>1o </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54126" pm="."><plain>M </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54127" pm="."><plain>MSX2 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54128" pm="."><plain>c.443C&gt;T </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54129" pm="."><plain>p.P148L </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54130" pm="."><plain>Heterozygous (from affected mother) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54131" pm="."><plain>33 34 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54132" pm="."><plain>BC </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54133" pm="."><plain>Mild learning difficulties, short, broad thumbs, 5th finger clinodactyly, thick hair, squint and hydrocoele </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="54134" pm="."><plain>11 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54135" pm="."><plain>M </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54136" pm="."><plain>FBN1 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54137" pm="."><plain>c.8226+5G&gt;A </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54138" pm="."><plain>Splice </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54139" pm="."><plain>De novo </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54140" pm="."><plain>35 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54141" pm="."><plain>S, M </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54142" pm="."><plain>Exorbitism, ligamentous laxity, recurrent inguinal herniae, tall stature; lens subluxation and mild aortic dilatation aged 8 years </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="54143" pm="."><plain>14 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54144" pm="."><plain>M </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54145" pm="."><plain>HUWE1 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54146" pm="."><plain>c.328C&gt;T </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54147" pm="."><plain>p.R110W </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54148" pm="."><plain>De novo </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54149" pm="."><plain>2 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54150" pm="."><plain>M </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54151" pm="."><plain>Facial dysmorphism, dental anomalies, pectus excavatum, scoliosis, long palms, Chiari malformation, moderate–severe intellectual disability </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="54152" pm="."><plain>16 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54153" pm="."><plain>M </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54154" pm="."><plain>ZIC1 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54155" pm="."><plain>c.1101C&gt;A </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54156" pm="."><plain>p.C367* </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54157" pm="."><plain>Suspected de novo§ </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54158" pm="."><plain>– </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54159" pm="."><plain>S, BL </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54160" pm="."><plain>Microcephaly, asymmetric ventriculomegaly, possible abnormalities on MRI brain imaging </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="54161" pm="."><plain>18 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54162" pm="."><plain>M </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54163" pm="."><plain>TWIST1 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54164" pm="."><plain>c.350A&gt;T </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54165" pm="."><plain>p.E117V </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54166" pm="."><plain>De novo </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54167" pm="."><plain>– </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54168" pm="."><plain>M </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54169" pm="."><plain>Hypertelorism, wide anterior fontanelle, upper eyelid colobomas, pseudoproptosis, dysplastic cupped ears, syndactyly of fingers, bilateral talipes, bilateral undescended testes, imperforate anus, hypertrichosis </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="54170" pm="."><plain>21 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54171" pm="."><plain>F </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54172" pm="."><plain>KRAS </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54173" pm="."><plain>c.40G&gt;A </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54174" pm="."><plain>p.V14I </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54175" pm="."><plain>De novo </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54176" pm="."><plain>36 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54177" pm="."><plain>P </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54178" pm="."><plain>Exorbitism, cloverleaf skull </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="54179" pm="."><plain>23 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54180" pm="."><plain>F+M </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54181" pm="."><plain>Novel¶ </plain></SENT>
</text></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"><text><SENT sid="54182" pm="."><plain>Compound heterozygous </plain></SENT>
</text></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"><text><SENT sid="54183" pm="."><plain>BC </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54184" pm="."><plain>Bilateral superior vena cava, dilated cardiomyopathy, rudimentary right thumb, duplex kidney, anterior anus, bilateral inguinal herniae, growth deficiency </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="54185" pm="."><plain>24 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54186" pm="."><plain>F </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54187" pm="."><plain>AHDC1 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54188" pm="."><plain>c.2373_2374delTG </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54189" pm="."><plain>p.C791fs*57 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54190" pm="."><plain>De novo </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54191" pm="."><plain>37 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54192" pm="."><plain>BC, M </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54193" pm="."><plain>Moderate developmental delay, hoarse cry </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="54194" pm="."><plain>25 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54195" pm="."><plain>F </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54196" pm="."><plain>EFNB1 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54197" pm="."><plain>c.325C&gt;T </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54198" pm="."><plain>p.R109C </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54199" pm="."><plain>Paternal </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54200" pm="."><plain>38 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54201" pm="."><plain>RC </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54202" pm="."><plain>Hypertelorism </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="54203" pm="."><plain>29 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54204" pm="."><plain>M </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54205" pm="."><plain>STAT3 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54206" pm="."><plain>c.1915C&gt;T </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54207" pm="."><plain>p.P639S </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54208" pm="."><plain>De novo </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54209" pm="."><plain>39 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54210" pm="."><plain>P </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54211" pm="."><plain>Crouzonoid appearance, mild global developmental delay; necrotising pneumonia and bronchopleural fistula aged 3 years </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="54212" pm="."><plain>37 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54213" pm="."><plain>F </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54214" pm="."><plain>NTRK2 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54215" pm="."><plain>c.1330G&gt;T </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54216" pm="."><plain>p.G444* </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54217" pm="."><plain>Suspected de novo§ </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54218" pm="."><plain>– </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54219" pm="."><plain>LC </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="54220" pm="."><plain>Facial asymmetry, progressive onset of aggressive outbursts, ritualised behaviours and language delay, hyperphagic obesity, streak ovaries </plain></SENT>
</text></td></tr></tbody></table><table-wrap-foot><fn><p><text><SENT sid="54221" pm="."><plain>†See online supplementary table S1 for detailed information. </plain></SENT>
</text></p></fn><fn><p><text><SENT sid="54222" pm="."><plain>‡Gene identity confirmed by functional testing (manuscript submitted). </plain></SENT>
</text></p></fn><fn><p><text><SENT sid="54223" pm="."><plain>§Father's sample not available for analysis. </plain></SENT>
</text></p></fn><fn><p><text><SENT sid="54224" pm="."><plain>¶Gene identity supported by similar case found on GeneMatcher; functional testing ongoing. </plain></SENT>
</text></p></fn><fn><p><text><SENT sid="54225" pm="."><plain>CRS, sutures fused in craniosynostosis: BC, bicoronal; BL, bilambdoid; LC, left coronal; LL, left lambdoid; M, metopic; P, pansynostosis; RC, right coronal; RL, right lambdoid; S, sagittal. </plain></SENT>
</text></p></fn></table-wrap-foot></table-wrap></SecTag><p><text><SENT sid="54226" pm="."><plain>Table 2 summarises the 13 cases or families with mutation in a validated disease gene. </plain></SENT>
<SENT sid="54227" pm="."><plain>Seven of the mutations identified (in AHDC1, EFNB1, FBN1, IL11RA, KRAS, MSX2, STAT3) were previously reported; in two instances (CDC45 and HUWE1), the patients contributed to the first reported disease gene identification;2 32 and in four cases, the mutations are newly identified and help to extend the genotype–phenotype spectrum (mutations in IL11RA, NTRK2, TWIST1, ZIC1). </plain></SENT>
<SENT sid="54228" pm="."><plain>The associated phenotypes are summarised in table 2, and complete details are provided in online supplementary table S1. </plain></SENT>
<SENT sid="54229" pm="."><plain>Aside from the importance of a molecular diagnosis to end the diagnostic odyssey and to enable precise genetic counselling (with appropriate estimation of recurrence risk and testing of at-risk family members), in five families the diagnosis had unexpected, actionable consequences for immediate clinical management. </plain></SENT>
<SENT sid="54230" pm="."><plain>Details of these latter cases are provided as brief case reports to illustrate the range of diagnostic and management issues encountered; more complete descriptions are provided as online supplementary case reports. </plain></SENT>
</text></p><supplementary-material content-type="local-data" id="SM3"><object-id pub-id-type="doi">10.1136/jmedgenet-2016-104215.supp3</object-id><label>supplementary case reports</label><p><text><SENT sid="54231" pm="."><plain> </plain></SENT>
</text></p></supplementary-material></sec><sec id="s3b"><title><text><SENT sid="54232" pm="."><plain>Case reports </plain></SENT>
</text></title><sec id="s3b1"><title><text><SENT sid="54233" pm="."><plain>Family 11: FBN1 mutation </plain></SENT>
</text></title><p><text><SENT sid="54234" pm="."><plain>This boy (II-3 in figure 1A) was initially diagnosed with Shprintzen-Goldberg syndrome based on the combination of sagittal synostosis, blue sclerae, micrognathia, ligamentous laxity, bilateral recurrent inguinal herniae, tall stature and mildly abnormal aortic contour on echocardiography. </plain></SENT>
<SENT sid="54235" pm="."><plain>However, sequencing of SKI, in addition to TGFBR1 and TGFBR2, did not reveal any mutations.40 </plain></SENT>
</text></p><SecTag type="FIG"><fig id="JMEDGENET2016104215F1" orientation="portrait" position="float"><label>Figure 1</label><caption><p><text><SENT sid="54236" pm="."><plain>Family pedigrees, clinical photographs/3D-CT scans and sequencing traces of families with mutations identified in FBN1 (A), EFNB1 (B) and STAT3 (C). </plain></SENT>
<SENT sid="54237" pm="."><plain>Each panel shows the location of the mutation (red line) within the gene structure (exons in blue), family pedigree (affected individuals are in black, black arrow depicts the proband and individuals selected for exome sequence/whole genome sequence are indicated with a red asterisk), sequence traces of indicated individuals (red arrow indicates position of mutation) and clinical photographs (B) and 3D-CT scans (C) of affected individuals. </plain></SENT>
<SENT sid="54238" pm="."><plain>Note facial asymmetry associated with right unicoronal synostosis in patient with EFNB1 mutation (B); there is moderate hypertelorism, but the grooving of the nasal tip usually observed in craniofrontonasal syndrome is absent. </plain></SENT>
<SENT sid="54239" pm="."><plain>In the patient with the STAT3 mutation (C), images with soft tissue windows (left and centre) show exorbitism, mid-face hypoplasia and vertex bulge; image with bone windows (right) shows fusion of all sutures of the skull vault. </plain></SENT>
</text></p></caption><graphic xlink:href="jmedgenet-2016-104215f01"/></fig></SecTag><p><text><SENT sid="54240" pm="."><plain>ES was performed on the proband only. </plain></SENT>
<SENT sid="54241" pm="."><plain>Concomitantly, the referring clinician reported that the patient, now aged 8 years, had presented with subluxed lenses; together with the aortic findings, this suggested possible Marfan syndrome (MFS). </plain></SENT>
<SENT sid="54242" pm="."><plain>Scrutiny of the ES data revealed two rare heterozygous variants in the FBN1 (Fibrillin 1) gene, c.2615A&gt;G (p.Lys872Arg) and c.8226+5G&gt;A. </plain></SENT>
<SENT sid="54243" pm="."><plain>Dideoxy-sequencing of parental samples showed that whereas the p.Lys872Arg substitution had been inherited from the unaffected father (not shown), the c.8226+5G&gt;A variant had arisen de novo (figure 1A). </plain></SENT>
<SENT sid="54244" pm="."><plain>The c.8226+5G&gt;A variant, which was reconfirmed in a diagnostic laboratory, has been identified previously in a patient with a progeroid variant of MFS;35 a different mutation of the same splice site (c.8226+1G&gt;A) was shown to cause skipping of the upstream exon, introducing a frameshift and premature stop codon.41 </plain></SENT>
</text></p><p><text><SENT sid="54245" pm="."><plain>Confirmation of the molecular diagnosis of MFS has triggered a programme of lifelong monitoring owing to the association with progressive aortic dilatation; aged 10 years, mild aortic root dilatation was observed (Z score=3.02). </plain></SENT>
<SENT sid="54246" pm="."><plain>Of note, craniosynostosis is an extremely rare but previously recognised association of MFS.42 43 </plain></SENT>
</text></p></sec><sec id="s3b2"><title><text><SENT sid="54247" pm="."><plain>Family 21: KRAS mutation </plain></SENT>
</text></title><p><text><SENT sid="54248" pm="."><plain>This girl presented neonatally with a cloverleaf skull appearance. </plain></SENT>
<SENT sid="54249" pm="."><plain>3D-CT revealed synostosis of multiple cranial sutures. </plain></SENT>
<SENT sid="54250" pm="."><plain>There were no additional syndromic features and cardiac examination was normal. </plain></SENT>
<SENT sid="54251" pm="."><plain>Raised intracranial pressure (ICP) was documented, requiring a posterior vault expansion with springs, performed at the age of 3 months, and insertion of a right parietooccipital ventriculoperitoneal shunt. </plain></SENT>
</text></p><p><text><SENT sid="54252" pm="."><plain>WGS of the parent–child trio identified a heterozygous de novo mutation (c.40G&gt;A encoding p.V14I) in KRAS, which has been reported previously in patients with Noonan syndrome.36 In the light of the exome results, an echocardiogram was performed, which was normal at almost 3 years of age, but she will continue cardiac surveillance. </plain></SENT>
<SENT sid="54253" pm="."><plain>A coagulation screen has been normal but recommendations have been made to repeat it prior to any future surgery. </plain></SENT>
<SENT sid="54254" pm="."><plain>Craniosynostosis is a rare but previously recognised complication of Noonan syndrome, being particularly associated with KRAS mutations.44 </plain></SENT>
</text></p></sec><sec id="s3b3"><title><text><SENT sid="54255" pm="."><plain>Family 25: EFNB1 mutation </plain></SENT>
</text></title><p><text><SENT sid="54256" pm="."><plain>The female proband (II-1 in figure 1B), the first-born child to healthy parents with no relevant family history, was noted to have facial asymmetry at birth. </plain></SENT>
<SENT sid="54257" pm="."><plain>Physical examination showed hypertelorism and ridging over the right coronal suture. </plain></SENT>
<SENT sid="54258" pm="."><plain>A 3D-CT scan confirmed right coronal synostosis. </plain></SENT>
<SENT sid="54259" pm="."><plain>She underwent a fronto-orbital advancement and remodelling (FOAR) procedure aged 15 months. </plain></SENT>
</text></p><p><text><SENT sid="54260" pm="."><plain>ES identified a heterozygous mutation (c.325C&gt;T; p.Arg109Cys) in the X-linked EFNB1 (ephrin-B1) gene, previously reported in a patient with craniofrontonasal syndrome (CFNS).38 Dideoxy sequencing of the parents showed that the clinically unaffected father (I-1) was hemizygous for the same variant (figure 1B). </plain></SENT>
<SENT sid="54261" pm="."><plain>CFNS presents a paradoxical pattern of severity for an X-linked disorder, with heterozygous females more severely affected than hemizygous males, who can be non-penetrant.45 The result predicts that 100% of female children of the father would be expected to exhibit CFNS and/or craniosynostosis, and the couple have elected to enrol in a programme of preimplantation genetic diagnosis (PIGD), selecting only male embryos for uterine transfer. </plain></SENT>
</text></p></sec><sec id="s3b4"><title><text><SENT sid="54262" pm="."><plain>Family 29: STAT3 mutation </plain></SENT>
</text></title><p><text><SENT sid="54263" pm="."><plain>This boy (II-1 in figure 1C) presented to the craniofacial unit at 2 years of age with mild mid-facial hypoplasia, a short nose with a convex ridge, exorbitism and mild global development delay; 3D-CT scan demonstrated fusion of all of the cranial sutures with convexity of the closed anterior fontanelle, prominent ventricles and crowded basal cisterns. </plain></SENT>
<SENT sid="54264" pm="."><plain>At the age of 2 years 2 months, ophthalmological assessment showed bilateral papilloedema and invasive monitoring demonstrated significantly raised ICP. </plain></SENT>
<SENT sid="54265" pm="."><plain>He underwent a posterior vault expansion with insertion of springs at the age of 28 months. </plain></SENT>
</text></p><p><text><SENT sid="54266" pm="."><plain>ES of the proband was performed. </plain></SENT>
<SENT sid="54267" pm="."><plain>This identified a heterozygous c.1915C&gt;T (p.Pro639Ser) mutation in the SH2 domain encoded by STAT3 (signal transducer and activator of transcription 3), which was previously reported in a case of hyper-IgE/Jobs syndrome.40 Dideoxy-sequencing of the parents showed that the mutation had arisen de novo (figure 1C). </plain></SENT>
</text></p><p><text><SENT sid="54268" pm="."><plain>Upon feedback of this finding, it transpired that the proband had more recently presented at the age of 3 years 3 months with an upper respiratory tract infection, progressing to severe necrotising pneumonia with a pulmonary abscess and pneumatocoele. </plain></SENT>
<SENT sid="54269" pm="."><plain>He developed a pneumothorax and bronchopleural fistula; following two unsuccessful attempts at surgical resection, he required a right lower lobe segmentectomy. </plain></SENT>
<SENT sid="54270" pm="."><plain>A large secundum atrial septal defect required patch closure at 5 years of age. </plain></SENT>
<SENT sid="54271" pm="."><plain>Further immunological assessment demonstrated a markedly elevated total IgE of 3091 kU/L (normal range 0–52). </plain></SENT>
<SENT sid="54272" pm="."><plain>He commenced prophylactic azithromycin and itraconazole and is awaiting a suitably matched donor for stem cell transplantation. </plain></SENT>
<SENT sid="54273" pm="."><plain>Bone mineral density assessment was normal, but he takes multivitamin supplements including vitamin D and is under enhanced dental and skeletal surveillance. </plain></SENT>
</text></p></sec><sec id="s3b5"><title><text><SENT sid="54274" pm="."><plain>Family 37: NTRK2 mutation </plain></SENT>
</text></title><p><text><SENT sid="54275" pm="."><plain>The female proband presented with an asymmetric face at 12 months of age and left coronal synostosis was diagnosed on 3D-CT scan; there were no syndromic features. </plain></SENT>
<SENT sid="54276" pm="."><plain>She underwent a FOAR procedure aged 17 months. </plain></SENT>
<SENT sid="54277" pm="."><plain>On clinical follow-up at the age of 2 years 8 months, she was noted to have episodes of temper tantrums and was exhibiting speech and language delay. </plain></SENT>
<SENT sid="54278" pm="."><plain>By the age of 6 years, she required a school statement indicating moderate learning difficulties. </plain></SENT>
<SENT sid="54279" pm="."><plain>ES identified a heterozygous nonsense mutation (c.1330G&gt;T; p.Gly444*) in NTRK2, encoding neurotrophic tyrosine receptor kinase, type 2, with a predicted loss of the entire intracellular tyrosine kinase domain. </plain></SENT>
<SENT sid="54280" pm="."><plain>The proband's mother did not carry the mutation and the father was not available for analysis. </plain></SENT>
<SENT sid="54281" pm="."><plain>Dominant mutations of NTRK2 have been described in association with hyperphagic obesity associated with developmental delay (OBHD), and functional studies have pointed to haploinsufficiency as the likely pathogenic mechanism of disease associated with a previously identified p.Tyr722Cys substitution.46 47 </plain></SENT>
</text></p><p><text><SENT sid="54282" pm="."><plain>The discovery of the NTRK2 mutation prompted a further endocrinology assessment at the age of 7 years 6 months. </plain></SENT>
<SENT sid="54283" pm="."><plain>Her height was 135.2 cm (+2.04 SD), weight 46.2 kg (+3.19 SD) and body mass index 25.3 kg/m2 (+3.1 SD), consistent with a diagnosis of OBHD. </plain></SENT>
<SENT sid="54284" pm="."><plain>She was noted to have a long-standing history of hyperphagia. </plain></SENT>
<SENT sid="54285" pm="."><plain>The oral glucose tolerance test was normal; streak ovaries and uterus were evident on ultrasound scan. </plain></SENT>
<SENT sid="54286" pm="."><plain>Management implications have included referral to a clinical psychologist and dietitian to address her eating behaviours, and regular monitoring for secondary complications including cardiovascular disease and diabetes. </plain></SENT>
</text></p></sec></sec></sec></SecTag><SecTag type="DISCUSS"><sec sec-type="discussion" id="s4"><title><text><SENT sid="54287" pm="."><plain>Discussion </plain></SENT>
</text></title><p><text><SENT sid="54288" pm="."><plain>We present, to our knowledge, the first investigation of the added value provided by ES or WGS in molecular genetic diagnosis of craniosynostosis, applied to two cohorts of patients (total of 40) identified as high-priority cases by clinical or laboratory geneticists following negative results from routine molecular genetic testing. </plain></SENT>
<SENT sid="54289" pm="."><plain>We identified 13 mutations in 12 confirmed disease genes that we considered to be pathogenic. </plain></SENT>
<SENT sid="54290" pm="."><plain>Seven of the particular DNA sequence changes found were previously reported, whereas an additional six are currently unique to the patients described here. </plain></SENT>
<SENT sid="54291" pm="."><plain>The newly identified variants were considered pathogenic using evidence from population MAF data, predictive computational data and studies of aberrant function (either performed ourselves or published in the literature), according to guidelines from the Association for Clinical Genetic Science.48 In addition, we identified at least two likely novel disease-associated genes; further studies to corroborate these findings are ongoing, so details are not presented here. </plain></SENT>
<SENT sid="54292" pm="."><plain>Including these latter cases, our overall success rate in identifying pathogenic mutations was 15/40 (37.5%), which is towards the upper end of the range usually quoted in ES/WGS analysis of other diseases with a major genetic component.1–3 We used a mixed strategy of sequencing both singletons and multiple family members; the latter strategy was associated with a higher success rate per family, but the former with a 2.3-fold higher success rate per sample sequenced. </plain></SENT>
<SENT sid="54293" pm="."><plain>Although trio sequencing is the favoured design in many other ES/WGS studies because complete bioinformatic analysis of the data is more straightforward,1–3 singleton sequencing appears more cost-effective in a diagnostic setting. </plain></SENT>
</text></p><p><text><SENT sid="54294" pm="."><plain>Craniosynostosis comprises a very diverse group of disorders and its causes are correspondingly heterogeneous, with intrauterine fetal head constraint, reduced transduction of stretch forces from the growing brain owing to poor intrinsic growth, and polygenic background all likely to play substantial roles, in addition to monogenic causes.8 Since a major motivation of this work was to use NGS to identify novel disease genes in craniosynostosis, we selected cases suspected to have a genetic cause, based on positive family history, presence of additional syndromic features or multiple suture fusions, and for which clinically guided genetic testing had been normal. </plain></SENT>
<SENT sid="54295" pm="."><plain>Although this strategy was successful, with at least four newly recognised disease genes for craniosynostosis being identified as part of this study (CDC4532 and HUWE1,2 and two awaiting further corroboration), the major finding presented here is that NGS is very valuable for diagnosis of a long ‘tail’ of rare genetic associations with craniosynostosis. </plain></SENT>
<SENT sid="54296" pm="."><plain>All of these positive diagnoses have made a critical difference to genetic counselling, with some having broader management implications. </plain></SENT>
</text></p><p><text><SENT sid="54297" pm="."><plain>To understand why a genetic diagnosis in craniosynostosis may elude standard molecular diagnostic testing, we categorised each additional diagnosis in terms of the molecular genetic framework recently presented by Twigg and Wilkie.8 These authors identified 57 genes as recurrently mutated in craniosynostosis, of which they categorised 20 as ‘core genes’ (craniosynostosis present in &gt;50% of patients with specific categories of mutation in that gene), while mutations in the remaining 37 genes were associated with craniosynostosis in only a minority of cases. </plain></SENT>
<SENT sid="54298" pm="."><plain>The core genes could be further subdivided into six with mutations each accounting for &gt;0.5% of all craniosynostosis and 14 more rarely mutated genes. Figure 2 summarises how the 13 identified mutations are classified according to this framework. </plain></SENT>
<SENT sid="54299" pm="."><plain>While, not surprisingly, the number of mutations identified, as a proportion of total genes in the category, rose progressively as the pathogenic hierarchy was ascended, there were multiple genes in each category. </plain></SENT>
<SENT sid="54300" pm="."><plain>This includes two genes (NTRK2, AHDC1), for which we are unaware of any previous association with craniosynostosis; it is unclear whether the co-occurrence of the mutation and sentinel phenotype is causally linked (potentially through the adverse effect of the mutation on brain development)8 or simply coincidental. </plain></SENT>
</text></p><SecTag type="FIG"><fig id="JMEDGENET2016104215F2" orientation="portrait" position="float"><label>Figure 2</label><caption><p><text><SENT sid="54301" pm="."><plain>Identified mutations and their association within the classification of craniosynostosis-associated genes proposed by Twigg and Wilkie.8 </plain></SENT>
</text></p></caption><graphic xlink:href="jmedgenet-2016-104215f02"/></fig></SecTag><p><text><SENT sid="54302" pm="."><plain>In the cases found to have mutations in the ‘core’ genes, the question arises why these were not identified by testing within the routine diagnostic service. </plain></SENT>
<SENT sid="54303" pm="."><plain>In the patients with EFNB1 and TWIST1 mutations, the diagnosis was missed because analysis of the relevant gene had not been requested by the clinician; either because of an unusually mild presentation (EFNB1, figure 1B) or a severe, atypical presentation (TWIST1). </plain></SENT>
<SENT sid="54304" pm="."><plain>Of the other core genes, homozygous mutations in IL11RA, first described in 2011,22 are increasingly recognised, especially in consanguineous families from the Indian subcontinent, and clinical diagnostic testing has now been introduced in the UK (<ext-link ext-link-type="uri" xlink:href="http://ukgtn.nhs.uk/uploads/tx_ukgtn/CRSDA_IL11RA_GD_Sept_14.pdf">http://ukgtn.nhs.uk/uploads/tx_ukgtn/CRSDA_IL11RA_GD_Sept_14.pdf</ext-link>). </plain></SENT>
<SENT sid="54305" pm="."><plain>Although a specific heterozygous mutation of MSX2 encoding Pro148His was the first molecular lesion to be described in craniosynostosis in 1993,49 only two further families (both segregating p.Pro148Leu) have subsequently been reported worldwide,33 34 and the family described here (also with p.Pro148Leu) is the first known in the UK. </plain></SENT>
<SENT sid="54306" pm="."><plain>Finally, the CDC45 patient contributed to the recent identification of mutations in this gene,32 and the patient with the ZIC1 mutation extends the currently described genotype–phenotype correlation,50 being the first with a mutation in exon 2 and also the first with involvement of the sagittal suture instead of the originally described presentation with bilateral coronal synostosis. </plain></SENT>
</text></p><p><text><SENT sid="54307" pm="."><plain>As in any branch of genetic medicine, achieving a precise molecular diagnosis has immediate implications for genetic counselling, both in terms of recurrence risk and for targeted preventive measures. </plain></SENT>
<SENT sid="54308" pm="."><plain>The common craniosynostosis syndromes all show dominant patterns of inheritance, so that when parents are clinically unaffected, empiric recurrence risks are low (around 5%).7 51 Our cohort illustrates two scenarios where providing the standard genetic advice would substantially underestimate recurrence risks. </plain></SENT>
<SENT sid="54309" pm="."><plain>In family 25 (EFNB1 mutation), the clinically unaffected father was shown to be hemizygous for the mutation originally identified in his daughter, indicating that the risk of CFNS in future female children is 100%. </plain></SENT>
<SENT sid="54310" pm="."><plain>In family 3 (CDC45 mutation), the autosomal-recessive inheritance of this disorder raises the recurrence risk for children of the unaffected parents to 25%. </plain></SENT>
<SENT sid="54311" pm="."><plain>Both findings have affected reproductive decision-making; one family is seeking PIGD, whereas in the other, the option not to have further children is being considered. </plain></SENT>
</text></p><p><text><SENT sid="54312" pm="."><plain>In addition to the genetic implications, in several cases (mutations in the FBN1, KRAS, NTRK2 and STAT3 genes), the molecular diagnosis has had immediate implications for clinical management, as described in the case reports, so genetic diagnosis was additionally important. </plain></SENT>
<SENT sid="54313" pm="."><plain>Mutations in each of these genes are only infrequently associated with craniosynostosis; indeed, the presence of the craniosynostosis may have delayed correct diagnosis by laying a confusing trail. </plain></SENT>
<SENT sid="54314" pm="."><plain>As a result of the molecular diagnosis, appropriate, potentially life-saving monitoring has been instigated. </plain></SENT>
<SENT sid="54315" pm="."><plain>The high apparent rate of rare actionable mutations identified in complex craniosynostosis without an obvious diagnosis may reflect developmental pleiotropy of signalling in the cranial sutures, with multiple pathways, co-opted from more ancient uses in embryogenesis, implicated at different stages of suture development.8 </plain></SENT>
</text></p><p><text><SENT sid="54316" pm="."><plain>In summary, our findings illustrate the considerable added value provided by ES/WGS to the precise diagnosis of patients with craniosynostosis suspected to have a genetic cause, but where routine testing has failed to elucidate this. </plain></SENT>
<SENT sid="54317" pm="."><plain>As technologies improve, a strategic question in molecular diagnostics is whether it is preferable to extend panel tests to more genes or whether to opt directly for ES/WGS. </plain></SENT>
<SENT sid="54318" pm="."><plain>Aside from the most common disease-associated mutations, for which targeted testing currently remains cost-effective, we propose, based on the distribution of mutations identified (figure 2), together with the substantial burden of actionable findings (case reports), a low threshold for implementing ES/WGS. </plain></SENT>
<SENT sid="54319" pm="."><plain>An additional benefit of this strategy is that it may identify new disease loci,2 32 enabling improved diagnostic and management strategies in the future. </plain></SENT>
</text></p></sec></SecTag><sec id="s5"><title><text><SENT sid="54320" pm="."><plain>Gene accession numbers </plain></SENT>
</text></title><p><text><SENT sid="54321" pm="."><plain>AHDC1 (NM_001029882), CDC45 (NM_003504), EFNB1 (NM_004429), FBN1 (NM_000138), HUWE1 (NM_031407), IL11RA (NM_001142784), KRAS (NM_033360), MSX2 (NM_002449), NTRK2 (NM_001007097), TWIST1 (NM_000474), STAT3 (NM_139276), ZIC1 (NM_003412). </plain></SENT>
</text></p></sec><sec id="s6"><title><text><SENT sid="54322" pm="."><plain>Web resources </plain></SENT>
</text></title><p><text><SENT sid="54323" pm="."><plain>MaxEntScan (<ext-link ext-link-type="uri" xlink:href="http://genes.mit.edu/burgelab/maxent/Xmaxentscan_scoreseq.html">http://genes.mit.edu/burgelab/maxent/Xmaxentscan_scoreseq.html</ext-link>) </plain></SENT>
</text></p><p><text><SENT sid="54324" pm="."><plain>NNSPLICE/BDGP (<ext-link ext-link-type="uri" xlink:href="http://www.fruitfly.org/seq_tools/splice.html">http://www.fruitfly.org/seq_tools/splice.html</ext-link>) </plain></SENT>
</text></p><p><text><SENT sid="54325" pm="."><plain>dbSNP (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/">http://www.ncbi.nlm.nih.gov/SNP/</ext-link>) </plain></SENT>
</text></p><p><text><SENT sid="54326" pm="."><plain>ExAC (<ext-link ext-link-type="uri" xlink:href="http://exac.broadinstitute.org/">http://exac.broadinstitute.org/</ext-link>) </plain></SENT>
</text></p><p><text><SENT sid="54327" pm="."><plain>GeneMatcher (https://genematcher.org/) </plain></SENT>
</text></p><p><text><SENT sid="54328" pm="."><plain>ClinVAR (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/clinvar/">http://www.ncbi.nlm.nih.gov/clinvar/</ext-link>) </plain></SENT>
</text></p><p><text><SENT sid="54329" pm="."><plain>LOVD (<ext-link ext-link-type="uri" xlink:href="http://databases.lovd.nl/shared/genes/ZIC1">http://databases.lovd.nl/shared/genes/ZIC1</ext-link>) </plain></SENT>
</text></p></sec></body><back><SecTag type="ACK_FUND"><ack><p><text4fund><text><SENT sid="54330" pm="."><plain>The authors are very grateful to all the families for their participation in this study. </plain></SENT>
<SENT sid="54331" pm="."><plain>The authors thank Ed Blair, Claire Bull, Helen Cox, Gillian Roberts, Vivienne Sutton and Denise Williams for patient referral and recruitments, Sue Butler, John Frankland and Tim Rostron for help with cell culture and DNA sequencing, staff at the High-Throughput Genomics facility at the Wellcome Trust Centre for Human Genetics (Oxford) for Illumina sequencing, and Nils Koelling for assistance with bioinformatics. </plain></SENT>
</text></text4fund></p></ack></SecTag><fn-group><fn><p><text><SENT sid="54332" pm="."><plain>Contributors: KAM, SRFT, JMP, ALF, DJ, SAW, PN, KEMR, EAT, JC, JT, JCT, JACG, IMJM, HL, TL, NA, DC, JAH, JEVM, ES, AW, LCW and AOMW contributed to patient recruitment, genetic or functional work. </plain></SENT>
<SENT sid="54333" pm="."><plain>SJM, SMAS and PJS performed bioinformatics analyses. </plain></SENT>
<SENT sid="54334" pm="."><plain>KAM and AOMW wrote the manuscript, with clinical input from NA, JAH, JEVM, AW and LCW. </plain></SENT>
</text></p></fn><SecTag type="ACK_FUND"><fn><p><text4fund><text><SENT sid="54335" pm="."><plain>Funding: Core facilities were supported by the WIMM Strategic Alliance (G0902418 and MC_UU_12025). </plain></SENT>
<SENT sid="54336" pm="."><plain>This work was supported by National Institute for Health Research (NIHR) Oxford Biomedical Research Centre Programme (JCT and AOMW), the Department of Health, UK, Quality, Improvement, Development and Initiative Scheme (QIDIS) (AOMW) and the Wellcome Trust (Project Grant 093329 to AOMW and SRFT, and Senior Investigator Award 102731 to AOMW). </plain></SENT>
</text></text4fund></p></fn></SecTag><fn><p><text><SENT sid="54337" pm="."><plain>Disclaimer: The views expressed in this publication are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. </plain></SENT>
</text></p></fn><fn fn-type="COI-statement"><p><text><SENT sid="54338" pm="."><plain>Competing interests: None declared. </plain></SENT>
</text></p></fn><fn><p><text><SENT sid="54339" pm="."><plain>Patient consent: Obtained. </plain></SENT>
</text></p></fn><fn><p><text><SENT sid="54340" pm="."><plain>Ethics approval: London—Riverside Research Ethics Committee (reference 09/H0706/20). </plain></SENT>
</text></p></fn><fn><p><text><SENT sid="54341" pm="."><plain>Provenance and peer review: Not commissioned; externally peer reviewed. </plain></SENT>
</text></p></fn><fn><p><text><SENT sid="54342" pm="."><plain>Data sharing statement: ES data for samples where we obtained the appropriate consent are available from the ENA under accession number PRJEB17650. </plain></SENT>
<SENT sid="54343" pm="."><plain>Previously unreported mutations, where we have obtained the relevant consent (ie, ZIC1), have been uploaded to the appropriate LOVD 3.0 shared installation locus specific database (Variant ID #0000127941). </plain></SENT>
</text></p></fn></fn-group><SecTag type="REF"><ref-list><title>References</title><ref id="R1"><text><SENT sid="54344" pm="."><plain>1GilissenC, Hehir-KwaJY, ThungDT, van de VorstM, van BonBW, WillemsenMH, KwintM, JanssenIM, HoischenA, SchenckA, LeachR, KleinR, TearleR, BoT, PfundtR, YntemaHG, de VriesBB, KleefstraT, BrunnerHG, VissersLE, VeltmanJA Genome sequencing identifies major causes of severe intellectual disability. Nature 2014;511:344–7. 10.1038/nature1339424896178 </plain></SENT>
</text></ref><ref id="R2"><text><SENT sid="54345" pm="."><plain>2TaylorJC, MartinHC, LiseS, BroxholmeJ, CazierJB, RimmerA, KanapinA, LunterG, FiddyS, AllanC, AricescuAR, AttarM, BabbsC, BecqJ, BeesonD, BentoC, BignellP, BlairE, BuckleVJ, BullK, CaisO, CarioH, ChapelH, CopleyRR, CornallR, CraftJ, DahanK, DavenportEE, DendrouC, DevuystO, FenwickAL, FlintJ, FuggerL, GilbertRD, GorielyA, GreenA, GregerIH, GrocockR, GruszczykAV, HastingsR, HattonE, HiggsD, HillA, HolmesC, HowardM, HughesL, HumburgP, JohnsonD, KarpeF, KingsburyZ, KiniU, KnightJC, KrohnJ, LambleS, LangmanC, LonieL, LuckJ, McCarthyD, McGowanSJ, McMullinMF, MillerKA, MurrayL, NemethAH, NesbitMA, NuttD, OrmondroydE, OturaiAB, PagnamentaA, PatelSY, PercyM, PetousiN, PiazzaP, PiretSE, Polanco-EcheverryG, PopitschN, PowrieF, PughC, QuekL, RobbinsPA, RobsonK, RussoA, SahgalN, van SchouwenburgPA, SchuhA, SilvermanE, SimmonsA, SorensenPS, SweeneyE, TaylorJ, ThakkerRV, TomlinsonI, TrebesA, TwiggSRF, UhligHH, VyasP, VyseT, WallSA, WatkinsH, WhyteMP, WittyL, WrightB, YauC, BuckD, HumphrayS, RatcliffePJ, BellJI, WilkieAOM, BentleyD, DonnellyP, McVeanG Factors influencing success of clinical genome sequencing across a broad spectrum of disorders. Nat Genet 2015;47:717–26. 10.1038/ng.330425985138 </plain></SENT>
</text></ref><ref id="R3"><text><SENT sid="54346" pm="."><plain>3Fitzgerald TWGS, JonesWD, van KogelenbergM, KingDA, McRaeJ, MorleyKI, ParthibanV, Al-TurkiS, AmbridgeK, BarrettDM, BayzetinovaT, ClaytonS, CoomberEL, GribbleS, JonesP, KrishnappaN, MasonLE, MiddletonA, MillerR, PrigmoreE, RajanD, SifrimA, TiveyAR, AhmedM, AkawiN, AndrewsR, AnjumU, ArcherH, ArmstrongR, BalasubramanianM, BanerjeeR, BaralleD, BatstoneP, BatyD, BennettC, BergJ, BernhardB, BevanAP, BlairE, BlythM, BohannaD, BourdonL, BournD, BradyA, BraginE, BrewerC, BruetonL, BrunstromK, BumpsteadSJ, BunyanDJ, BurnJ, BurtonJ, CanhamN, CastleB, ChandlerK, ClasperS, Clayton-SmithJ, ColeT, CollinsA, CollinsonMN, ConnellF, CooperN, CoxH, CresswellL, CrossG, CrowY, D'AlessandroM, DabirT, DavidsonR, DaviesS, DeanJ, DeshpandeC, DevlinG, DixitA, DominiczakA, DonnellyC, DonnellyD, DouglasA, DuncanA, EasonJ, EdkinsS, EllardS, EllisP, ElmslieF, EvansK, EverestS, FendickT, FisherR, FlinterF, FouldsN, FryerA, FuB, GardinerC, GauntL, GhaliN, GibbonsR, Gomes PereiraSL, GoodshipJ, GoudieD, GrayE, GreeneP, GreenhalghL, HarrisonL, HawkinsR, HellensS, HendersonA, HobsonE, HoldenS, HolderS, HollingsworthG, HomfrayT, HumphreysM, HurstJ, IngramS, IrvingM, JarvisJ, JenkinsL, JohnsonD, JonesD, JonesE, JosifovaD, JossS, KaembaB, KazembeS, KerrB, KiniU, KinningE, KirbyG, KirkC, KivuvaE, KrausA, KumarD, LachlanK, LamW, LampeA, LangmanC, LeesM, LimD, LowtherG, LynchSA, MageeA, MaherE, MansourS, MarksK, MartinK, MayeU, McCannE, McConnellV, McEntagartM, McGowanR, McKayK, McKeeS, McMullanDJ, McNerlanS, MehtaS, MetcalfeK, MilesE, MohammedS, MontgomeryT, MooreD, MorganS, MorrisA, MortonJEV, MugalaasiH, MurdayV, NevittL, Newbury-EcobR, NormanA, O'SheaR, OgilvieC, ParkS, ParkerMJ, PatelC, PatersonJ, PayneS, PhippsJ, PilzDT, PorteousD, PrattN, PrescottK, PriceS, PridhamA, ProcterA, PurnellH, RaggeN, RankinJ, RaymondL, RiceD, RobertL, RobertsE, RobertsG, RobertsJ, RobertsP, RossA, RosserE, SaggarA, SamantS, SandfordR, SarkarA, SchweigerS, ScottC, ScottR, SelbyA, SellerA, SequeiraC, ShannonN, SharifS, Shaw-SmithC, ShearingE, ShearsD, SimonicI, SimpkinD, SingzonR, SkittZ, SmithA, SmithB, SmithK, SmithsonS, SneddonL, SplittM, SquiresM, StewartF, StewartH, SuriM, SuttonV, SwaminathanGJ, SweeneyE, Tatton-BrownK, TaylorC, TaylorR, TeinM, TempleIK, ThomsonJ, TolmieJ, TorokwaA, TreacyB, TurnerC, TurnpennyP, TysoeC, VandersteenA, VasudevanP, VogtJ, WakelingE, WalkerD, WatersJ, WeberA, WellesleyD, WhitefordM, WidaaS, WilcoxS, WilliamsD, WilliamsN, WoodsG, WraggC, WrightM, YangF, YauM, CarterNP, ParkerM, FirthHV, FitzPatrickDR, WrightCF, BarrettJC, HurlesME Large-scale discovery of novel genetic causes of developmental disorders. Nature 2015;519:223–8. 10.1038/nature1413525533962 </plain></SENT>
</text></ref><ref id="R4"><text><SENT sid="54347" pm="."><plain>4BouletSL, RasmussenSA, HoneinMA A population-based study of craniosynostosis in metropolitan Atlanta, 1989-2003. Am J Med Genet A 2008;146A:984–91. 10.1002/ajmg.a.3220818344207 </plain></SENT>
</text></ref><ref id="R5"><text><SENT sid="54348" pm="."><plain>5LajeunieE, Le MerrerM, Bonaiti-PellieC, MarchacD, RenierD Genetic study of nonsyndromic coronal craniosynostosis. Am J Med Genet 1995;55:500–4. 10.1002/ajmg.13205504227762595 </plain></SENT>
</text></ref><ref id="R6"><text><SENT sid="54349" pm="."><plain>6Morriss-KayGM, WilkieAOM Growth of the normal skull vault and its alteration in craniosynostosis: insights from human genetics and experimental studies. J Anat 2005;207:637–53. 10.1111/j.1469-7580.2005.00475.x16313397 </plain></SENT>
</text></ref><ref id="R7"><text><SENT sid="54350" pm="."><plain>7JohnsonD, WilkieAOM Craniosynostosis. Eur J Hum Genet 2011;19:369–76. 10.1038/ejhg.2010.23521248745 </plain></SENT>
</text></ref><ref id="R8"><text><SENT sid="54351" pm="."><plain>8TwiggSRF, WilkieAOM A genetic-pathophysiological framework for craniosynostosis. Am J Hum Genet 2015;97:359–77. 10.1016/j.ajhg.2015.07.00626340332 </plain></SENT>
</text></ref><ref id="R9"><text><SENT sid="54352" pm="."><plain>9CohenMM, MacLeanRE Craniosynostosis: diagnosis, evaluation, and management. 2nd edn USA: Oxford University Press, 2000. </plain></SENT>
</text></ref><ref id="R10"><text><SENT sid="54353" pm="."><plain>10WilkieAOM, ByrenJC, HurstJA, JayamohanJ, JohnsonD, KnightSJ, LesterT, RichardsPG, TwiggSRF, WallSA Prevalence and complications of single-gene and chromosomal disorders in craniosynostosis. Pediatr 2010;126:e391–400. 10.1542/peds.2009-3491 </plain></SENT>
</text></ref><ref id="R11"><text><SENT sid="54354" pm="."><plain>11ReardonW, WinterRM, RutlandP, PulleynLJ, JonesBM, MalcolmS Mutations in the fibroblast growth factor receptor 2 gene cause Crouzon syndrome. Nat Genet 1994;8:98–103. 10.1038/ng0994-987987400 </plain></SENT>
</text></ref><ref id="R12"><text><SENT sid="54355" pm="."><plain>12JabsEW, LiX, ScottAF, MeyersG, ChenW, EcclesM, MaoJI, CharnasLR, JacksonCE, JayeM Jackson-Weiss and Crouzon syndromes are allelic with mutations in fibroblast growth factor receptor 2. Nat Genet 1994;8:275–9. 10.1038/ng1194-2757874170 </plain></SENT>
</text></ref><ref id="R13"><text><SENT sid="54356" pm="."><plain>13WilkieAOM, SlaneySF, OldridgeM, PooleMD, AshworthGJ, HockleyAD, HaywardRD, DavidDJ, PulleynLJ, RutlandP, MalcolmS, WinterRM, ReardonW Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome. Nat Genet 1995;9:165–72. 10.1038/ng0295-1657719344 </plain></SENT>
</text></ref><ref id="R14"><text><SENT sid="54357" pm="."><plain>14BellusGA, GaudenzK, ZackaiEH, ClarkeLA, SzaboJ, FrancomanoCA, MuenkeM Identical mutations in three different fibroblast growth factor receptor genes in autosomal dominant craniosynostosis syndromes. Nat Genet 1996;14:174–6. 10.1038/ng1096-1748841188 </plain></SENT>
</text></ref><ref id="R15"><text><SENT sid="54358" pm="."><plain>15el GhouzziV, Le MerrerM, Perrin-SchmittF, LajeunieE, BenitP, RenierD, BourgeoisP, Bolcato-BelleminAL, MunnichA, BonaventureJ Mutations of the TWIST gene in the Saethre-Chotzen syndrome. Nat Genet 1997;15:42–6. 10.1038/ng0197-428988167 </plain></SENT>
</text></ref><ref id="R16"><text><SENT sid="54359" pm="."><plain>16HowardTD, PaznekasWA, GreenED, ChiangLC, MaN, Ortiz de LunaRI, Garcia DelgadoC, Gonzalez-RamosM, KlineAD, JabsEW Mutations in TWIST, a basic helix-loop-helix transcription factor, in Saethre-Chotzen syndrome. Nat Genet 1997;15:36–41. 10.1038/ng0197-368988166 </plain></SENT>
</text></ref><ref id="R17"><text><SENT sid="54360" pm="."><plain>17SharmaVP, FenwickAL, BrockopMS, McGowanSJ, GoosJAC, HoogeboomAJ, BradyAF, JeelaniNO, LynchSA, MullikenJB, MurrayDJ, PhippsJM, SweeneyE, TomkinsSE, WilsonLC, BennettS, CornallRJ, BroxholmeJ, KanapinA, Whole-Genome SequencesC, JohnsonD, WallSA, van der SpekPJ, MathijssenIMJ, MaxsonRE, TwiggSRF, WilkieAOM Mutations in TCF12, encoding a basic helix-loop-helix partner of TWIST1, are a frequent cause of coronal craniosynostosis. Nat Genet 2013;45:304–7. 10.1038/ng.253123354436 </plain></SENT>
</text></ref><ref id="R18"><text><SENT sid="54361" pm="."><plain>18TwiggSRF, VorgiaE, McGowanSJ, PerakiI, FenwickAL, SharmaVP, AllegraM, ZaragkouliasA, Sadighi AkhaE, KnightSJ, LordH, LesterT, IzattL, LampeAK, MohammedSN, StewartFJ, VerloesA, WilsonLC, HealyC, SharpePT, HammondP, HughesJ, TaylorS, JohnsonD, WallSA, MavrothalassitisG, WilkieAOM Reduced dosage of ERF causes complex craniosynostosis in humans and mice and links ERK1/2 signaling to regulation of osteogenesis. Nat Genet 2013;45:308–13. 10.1038/ng.253923354439 </plain></SENT>
</text></ref><ref id="R19"><text><SENT sid="54362" pm="."><plain>19TwiggSRF, KanR, BabbsC, BochukovaEG, RobertsonSP, WallSA, Morriss-KayGM, WilkieAOM Mutations of ephrin-B1 (EFNB1), a marker of tissue boundary formation, cause craniofrontonasal syndrome. Proc Natl Acad Sci USA 2004;101:8652–7. 10.1073/pnas.040281910115166289 </plain></SENT>
</text></ref><ref id="R20"><text><SENT sid="54363" pm="."><plain>20TwiggSRF, HufnagelRB, MillerKA, ZhouY, McGowanSJ, TaylorJ, CraftJ, TaylorJC, SantoroSL, HuangT, HopkinRJ, BradyAF, Clayton-SmithJ, ClericuzioCL, GrangeDK, GroesserL, HafnerC, HornD, TempleIK, DobynsWB, CurryCJ, JonesMC, WilkieAOM A recurrent mosaic mutation in SMO, encoding the Hedgehog signal transducer smoothened, is the major cause of Curry-Jones syndrome. Am J Hum Genet 2016;98:1256–65. 10.1016/j.ajhg.2016.04.00727236920 </plain></SENT>
</text></ref><ref id="R21"><text><SENT sid="54364" pm="."><plain>21FennellN, FouldsN, JohnsonDS, WilsonLC, WyattM, RobertsonSP, JohnsonD, WallSA, WilkieAOM Association of mutations in FLNA with craniosynostosis. Eur J Hum Genet 2015;23:1684–8. 10.1038/ejhg.2015.3125873011 </plain></SENT>
</text></ref><ref id="R22"><text><SENT sid="54365" pm="."><plain>22NieminenP, MorganNV, FenwickAL, ParmanenS, VeistinenL, MikkolaML, van der SpekPJ, GiraudA, JuddL, ArteS, BruetonLA, WallSA, MathijssenIMJ, MaherER, WilkieAOM, KreiborgS, ThesleffI Inactivation of IL11 signaling causes craniosynostosis, delayed tooth eruption, and supernumerary teeth. Am J Hum Genet 2011;89:67–81. 10.1016/j.ajhg.2011.05.02421741611 </plain></SENT>
</text></ref><ref id="R23"><text><SENT sid="54366" pm="."><plain>23DrmanacR, SparksAB, CallowMJ, HalpernAL, BurnsNL, KermaniBG, CarnevaliP, NazarenkoI, NilsenGB, YeungG, DahlF, FernandezA, StakerB, PantKP, BaccashJ, BorcherdingAP, BrownleyA, CedenoR, ChenL, ChernikoffD, CheungA, ChiritaR, CursonB, EbertJC, HackerCR, HartlageR, HauserB, HuangS, JiangY, KarpinchykV, KoenigM, KongC, LandersT, LeC, LiuJ, McBrideCE, MorenzoniM, MoreyRE, MutchK, PerazichH, PerryK, PetersBA, PetersonJ, PethiyagodaCL, PothurajuK, RichterC, RosenbaumAM, RoyS, ShaftoJ, SharanhovichU, ShannonKW, SheppyCG, SunM, ThakuriaJV, TranA, VuD, ZaranekAW, WuX, DrmanacS, OliphantAR, BanyaiWC, MartinB, BallingerDG, ChurchGM, ReidCA Human genome sequencing using unchained base reads on self-assembling DNA nanoarrays. Science 2010;327:78–81. 10.1126/science.118149819892942 </plain></SENT>
</text></ref><ref id="R24"><text><SENT sid="54367" pm="."><plain>24LangmeadB, SalzbergSL Fast gapped-read alignment with Bowtie 2. Nat Methods 2012;9:357–9. 10.1038/nmeth.192322388286 </plain></SENT>
</text></ref><ref id="R25"><text><SENT sid="54368" pm="."><plain>25LiH, HandsakerB, WysokerA, FennellT, RuanJ, HomerN, MarthG, AbecasisG, DurbinR The Sequence Alignment/Map format and SAMtools. Bioinformatics 2009;25:2078–9. 10.1093/bioinformatics/btp35219505943 </plain></SENT>
</text></ref><ref id="R26"><text><SENT sid="54369" pm="."><plain>26RimmerA, PhanH, MathiesonIMJ, IqbalZ, TwiggSRF, WilkieAOM, McVeanG, LunterG Integrating mapping-, assembly- and haplotype-based approaches for calling variants in clinical sequencing applications. Nat Genet 2014;46:912–18. 10.1038/ng.303625017105 </plain></SENT>
</text></ref><ref id="R27"><text><SENT sid="54370" pm="."><plain>27FuW, O'ConnorTD, JunG, KangHM, AbecasisG, LealSM, GabrielS, RiederMJ, AltshulerD, ShendureJ, NickersonDA, BamshadMJ, AkeyJM Analysis of 6,515 exomes reveals the recent origin of most human protein-coding variants. Nature 2013;493:216–20. 10.1038/nature1169023201682 </plain></SENT>
</text></ref><ref id="R28"><text><SENT sid="54371" pm="."><plain>28WangK, LiM, HakonarsonH ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nuc Acid Res 2010;38:e164 10.1093/nar/gkq603 </plain></SENT>
</text></ref><ref id="R29"><text><SENT sid="54372" pm="."><plain>29YeoG, BurgeCB Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals. J Comput Biol 2004;11:377–94. 10.1089/106652704141041815285897 </plain></SENT>
</text></ref><ref id="R30"><text><SENT sid="54373" pm="."><plain>30LandrumMJ, LeeJM, RileyGR, JangW, RubinsteinWS, ChurchDM, MaglottDR ClinVar: public archive of relationships among sequence variation and human phenotype. Nuc Acid Res 2014;42:D980–5. 10.1093/nar/gkt1113 </plain></SENT>
</text></ref><ref id="R31"><text><SENT sid="54374" pm="."><plain>31SteinLD, MungallC, ShuS, CaudyM, MangoneM, DayA, NickersonE, StajichJE, HarrisTW, ArvaA, LewisS The generic genome browser: a building block for a model organism system database. Genome Res 2002;12:1599–610. 10.1101/gr.40360212368253 </plain></SENT>
</text></ref><ref id="R32"><text><SENT sid="54375" pm="."><plain>32FenwickAL, KliszczakM, CooperF, MurrayJ, Sanchez-PulidoL, TwiggSRF, GorielyA, McGowanSJ, MillerKA, TaylorIB, LoganC, BozdoganS, DandaS, DixonJ, ElsayedSM, ElsobkyE, GardhamA, HofferMJ, KoopmansM, McDonald-McGinnDM, SantenGW, SavarirayanR, de SilvaD, VanakkerO, WallSA, WilsonLC, YuregirOO, ZackaiEH, PontingCP, JacksonAP, WilkieAOM, NiedzwiedzW, BicknellLS Mutations in CDC45, encoding an essential component of the pre-initiation complex, cause Meier-Gorlin syndrome and craniosynostosis. Am J Hum Genet 2016;99:125–38. 10.1016/j.ajhg.2016.05.01927374770 </plain></SENT>
</text></ref><ref id="R33"><text><SENT sid="54376" pm="."><plain>33FlorissonJM, VerkerkAJ, HuighD, HoogeboomAJ, SwagemakersSMA, KremerA, HeijsmanD, LequinMH, MathijssenIMJ, van der SpekPJ Boston type craniosynostosis: report of a second mutation in MSX2. Am J Med Genet A 2013;161A:2626–33. 10.1002/ajmg.a.3612623949913 </plain></SENT>
</text></ref><ref id="R34"><text><SENT sid="54377" pm="."><plain>34JanssenA, HosenMJ, JeanninP, CouckePJ, De PaepeA, VanakkerOM Second family with the Boston-type craniosynostosis syndrome: novel mutation and expansion of the clinical spectrum. Am J Med Genet A 2013;161A:2352–7. 10.1002/ajmg.a.3607723918290 </plain></SENT>
</text></ref><ref id="R35"><text><SENT sid="54378" pm="."><plain>35KempersM, SaleminkS, SpruijtL, MarcelisC, LoeysB Unusual presentations of thoracic aortic aneurysm in children [abstract]. </plain></SENT>
<SENT sid="54379" pm="."><plain>In: The Fourth Cardiff Cardiovascular Genetics Symposium “Current trends in diagnosis and therapies” 2013; Cardiff, UK. </plain></SENT>
</text></ref><ref id="R36"><text><SENT sid="54380" pm="."><plain>36SchubbertS, ZenkerM, RoweSL, BollS, KleinC, BollagG, van der BurgtI, MusanteL, KalscheuerV, WehnerLE, NguyenH, WestB, ZhangKY, SistermansE, RauchA, NiemeyerCM, ShannonK, KratzCP Germline KRAS mutations cause Noonan syndrome. Nat Genet 2006;38:331–6. 10.1038/ng174816474405 </plain></SENT>
</text></ref><ref id="R37"><text><SENT sid="54381" pm="."><plain>37XiaF, BainbridgeMN, TanTY, WanglerMF, ScheuerleAE, ZackaiEH, HarrMH, SuttonVR, NalamRL, ZhuW, NashM, RyanMM, Yaplito-LeeJ, HunterJV, DeardorffMA, PenneySJ, BeaudetAL, PlonSE, BoerwinkleEA, LupskiJR, EngCM, MuznyDM, YangY, GibbsRA De novo truncating mutations in AHDC1 in individuals with syndromic expressive language delay, hypotonia, and sleep apnea. Am J Hum Genet 2014;94:784–9. 10.1016/j.ajhg.2014.04.00624791903 </plain></SENT>
</text></ref><ref id="R38"><text><SENT sid="54382" pm="."><plain>38WallisD, LacbawanF, JainM, Der KaloustianVM, SteinerCE, MoeschlerJB, LoskenHW, KaitilaII, CantrellS, ProudVK, CareyJC, DayDW, LevD, TeebiAS, RobinsonLK, HoymeHE, Al-TorkiN, Siegel-BarteltJ, MullikenJB, RobinNH, SaavedraD, ZackaiEH, MuenkeM Additional EFNB1 mutations in craniofrontonasal syndrome. Am J Med Genet A 2008;146A:2008–12. 10.1002/ajmg.a.3238818627045 </plain></SENT>
</text></ref><ref id="R39"><text><SENT sid="54383" pm="."><plain>39WoellnerC, GertzEM, SchafferAA, LagosM, PerroM, GlockerEO, PietrograndeMC, CossuF, FrancoJL, MatamorosN, PietruchaB, Heropolitanska-PliszkaE, YeganehM, MoinM, EspanolT, EhlS, GenneryAR, AbinunM, BreborowiczA, NiehuesT, KilicSS, JunkerA, TurveySE, PlebaniA, SanchezB, GartyBZ, PignataC, CancriniC, LitzmanJ, SanalO, BaumannU, BacchettaR, HsuAP, DavisJN, HammarstromL, DaviesEG, ErenE, ArkwrightPD, MoilanenJS, ViemannD, KhanS, MarodiL, CantAJ, FreemanAF, PuckJM, HollandSM, GrimbacherB Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome. J Allergy Clin Immunol 2010;125:424–32.e8. 10.1016/j.jaci.2009.10.05920159255 </plain></SENT>
</text></ref><ref id="R40"><text><SENT sid="54384" pm="."><plain>40SchepersD, DoyleAJ, OswaldG, SparksE, MyersL, WillemsPJ, MansourS, SimpsonMA, FrysiraH, Maat-KievitA, Van MinkelenR, HoogeboomJM, MortierGR, TitheradgeH, BruetonL, StarrL, StarkZ, OckeloenC, LourencoCM, BlairE, HobsonE, HurstJ, MaystadtI, DestreeA, GirishaKM, MillerM, DietzHC, LoeysB, Van LaerL The SMAD-binding domain of SKI: a hotspot for de novo mutations causing Shprintzen-Goldberg syndrome. Eur J Hum Genet 2015;23:224–8. 10.1038/ejhg.2014.6124736733 </plain></SENT>
</text></ref><ref id="R41"><text><SENT sid="54385" pm="."><plain>41JacquinetA, VerloesA, CallewaertB, CoremansC, CouckeP, de PaepeA, KornakU, LebrunF, LombetJ, PierardGE, RobinsonPN, SymoensS, Van MaldergemL, DebrayFG Neonatal progeroid variant of Marfan syndrome with congenital lipodystrophy results from mutations at the 3′ end of FBN1 gene. Eur J Med Genet 2014;57:230–4. 10.1016/j.ejmg.2014.02.01224613577 </plain></SENT>
</text></ref><ref id="R42"><text><SENT sid="54386" pm="."><plain>42KosakiK, TakahashiD, UdakaT, KosakiR, MatsumotoM, IbeS, IsobeT, TanakaY, TakahashiT Molecular pathology of Shprintzen-Goldberg syndrome. Am J Med Genet 2006;140A:104–8. 10.1002/ajmg.a.31006 </plain></SENT>
</text></ref><ref id="R43"><text><SENT sid="54387" pm="."><plain>43SoodS, EldadahZA, KrauseWL, McIntoshI, DietzHC Mutation in fibrillin-1 and the Marfanoid-craniosynostosis (Shprintzen-Goldberg) syndrome. Nat Genet 1996;12: 209–11. 10.1038/ng0296-2098563763 </plain></SENT>
</text></ref><ref id="R44"><text><SENT sid="54388" pm="."><plain>44AddissieYA, KotechaU, HartRA, MartinezAF, KruszkaP, MuenkeM Craniosynostosis and Noonan syndrome with KRAS mutations: Expanding the phenotype with a case report and review of the literature. Am J Med Genet A 2015;167A:2657–63. 10.1002/ajmg.a.3725926249544 </plain></SENT>
</text></ref><ref id="R45"><text><SENT sid="54389" pm="."><plain>45OzylmazB, GezdiriciA, OzenM, KalendererO Report of a family with craniofrontonasal syndrome. Clin Dysmorphol 2015;24:79–83. 10.1097/MCD.000000000000006725486017 </plain></SENT>
</text></ref><ref id="R46"><text><SENT sid="54390" pm="."><plain>46YeoGS, Connie HungCC, RochfordJ, KeoghJ, GrayJ, SivaramakrishnanS, O'RahillyS, FarooqiIS A de novo mutation affecting human TrkB associated with severe obesity and developmental delay. Nat Neurosci 2004;7:1187–9. 10.1038/nn133615494731 </plain></SENT>
</text></ref><ref id="R47"><text><SENT sid="54391" pm="."><plain>47GrayJ, YeoG, HungC, KeoghJ, ClaytonP, BanerjeeK, McAulayA, O'RahillyS, FarooqiIS Functional characterization of human NTRK2 mutations identified in patients with severe early-onset obesity. Int J Obes 2007;31:359–64. 10.1038/sj.ijo.0803390 </plain></SENT>
</text></ref><ref id="R48"><text><SENT sid="54392" pm="."><plain>48WallisY, PayneS, McAnultyC, BodmerD, SistermansE, RobertsonK, MooreD, AbbsS, DeansZ, DevereauA Practice guidelines for the evaluation of pathogenicity and the reporting of sequence variants in clinical molecular genetics. </plain></SENT>
<SENT sid="54393" pm="."><plain>In: Association for clinical genetic science, 2013 http://www.acgs.uk.com/media/774853/evaluation_and_reporting_of_sequence_variants_bpgs_june_2013_-_finalpdf.pdf (accessed 15 Jul 2016). </plain></SENT>
</text></ref><ref id="R49"><text><SENT sid="54394" pm="."><plain>49JabsEW, MullerU, LiX, MaL, LuoW, HaworthIS, KlisakI, SparkesR, WarmanML, MullikenJB, SneadML, MaxsonR A mutation in the homeodomain of the human MSX2 gene in a family affected with autosomal dominant craniosynostosis. Cell 1993;75:443–50. 10.1016/0092-8674(93)90379-58106171 </plain></SENT>
</text></ref><ref id="R50"><text><SENT sid="54395" pm="."><plain>50TwiggSRF, ForeckiJ, GoosJAC, RichardsonIC, HoogeboomAJ, van den OuwelandAM, SwagemakersSMA, LequinMH, Van AntwerpD, McGowanSJ, WestburyI, MillerKA, WallSA, van der SpekPJ, MathijssenIMJ, PauwsE, MerzdorfCS, WilkieAOM Gain-of-function mutations in ZIC1 are associated with coronal craniosynostosis and learning disability. Am J Hum Genet 2015;97:378–88. 10.1016/j.ajhg.2015.07.00726340333 </plain></SENT>
</text></ref><ref id="R51"><text><SENT sid="54396" pm="."><plain>51GreenwoodJ, FlodmanP, OsannK, BoyadjievSA, KimonisV Familial incidence and associated symptoms in a population of individuals with nonsyndromic craniosynostosis. Genet Med 2014;16:302–10. 10.1038/gim.2013.13424071792 </plain></SENT>
</text></ref></ref-list></SecTag></back></article>
